Taiho Oncology
Develops and sells oral cancer medications for various tumors.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2002
- Employees
- 350
- Headquarters
- United States
- Type
- Public
- Listed
- Tokyo Stock Exchange: 4578
- Subsidiaries
- Taiho Oncology Europe, Taiho Pharma Canada
Open positions
14 jobs